SCHEMBL8627340

SCHEMBL8627340

CCCC(N)(C1CC1)C1CC1

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39548 0.87 CYP1A2 (0.39)
SCHEMBL7094303 0.79 ALDH1A1 (0.39)
SCHEMBL20751502 0.76
SCHEMBL10987812 0.74
SCHEMBL11336233 0.71 CYP1A2 (0.43) FDPS
SCHEMBL14473861 0.71 CYP1A2 (0.43) FDPS
SCHEMBL14504926 0.71 CYP1A2 (0.43) FDPS
SCHEMBL23542637 0.67
SCHEMBL75236 0.67
SCHEMBL10306785 0.67 FDPS (0.33) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846108-A1 AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 1998-06-10 EP disclosed
WO-1996039400-A1 AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 1996-12-12 WO disclosed